Regulatory & Legal

Invisors earns top workplace honors in the US and UK with a 95% employee approval rating. We explore how trust and unique perks build a winning global culture.

The medical device giant posts 6% Q1 growth but faces major challenges from US reimbursement changes and a China recall, banking on a new acquisition.

Struggling garment and logistics firm Addentax Group announces a radical pivot, proposing to acquire an AI-powered crypto wealth platform in a bold move.

The high-tech wheel maker's stock plummets 65% as it fails to meet listing rules, signaling deep financial and operational distress for the company.

Republic Technologies taps Canadian Solar’s CFO, signaling a strategic move to blend traditional financial discipline with Web3 infrastructure development.

A small-cap food company plans a major NASDAQ leap, but its future hinges on a secret 'clean' technology. Can this ambitious, risky pivot succeed?

Amid Chapter 11 liquidation, LiDAR firm Luminar sells off key assets to pay creditors, offering to buy back senior notes at a premium.

New clinical data reveals a minimally invasive spine implant significantly cuts pain, improves function, and reduces opioid use for SI joint dysfunction.

Ernexa Therapeutics secures crucial funding for its cancer therapy pipeline, but the dilutive offering sends its stock plunging more than 50%.

Strong investor demand boosts financing for BC's Golden Triangle exploration, highlighting Canada's strategic push into the critical minerals sector.

The cybersecurity leader's new DSPM capabilities aim to solve the AI data dilemma, promising to protect the entire AI innovation lifecycle.

Brokerage Quantfury partners with creative agency Sandwich to fight trading gamification. Can a commercial series change investor behavior for good?

South Korean firm Neurophet wins its third FDA clearance for an AI tool that precisely tracks Alzheimer's therapy side effects, eyeing U.S. expansion.

China's 2026 tax overhaul offers major breaks for the domestic service industry. E-Home is seizing the opportunity to invest in AI and service quality.

India's top university is planting its flag in the US, launching a new foundation to accelerate deep-tech startups and forge a transatlantic tech pipeline.

Australian biotech Immutep reaches a key milestone in its Phase III trial for a novel lung cancer therapy, a major step in a multi-billion dollar market.

With a new celebrity ad, CoreWeave is making a play for AI dominance. But can its specialized tech overcome financial risks and challenge industry giants?

For the 14th straight year, Herzing University earns top U.S. News rankings. Discover the model of support and career focus driving its sustained success.

Marex's acquisition of Webb Traders signals a major push into automated equity derivatives, aiming to internalize hedging and challenge market norms.

The fintech firm is pivoting hard into digital assets, planning to mine Bitcoin Cash while launching a novel crypto life insurance business in Bermuda.